Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders

Lancet. 1999 Jul 10;354(9173):131-2. doi: 10.1016/S0140-6736(98)04793-X.

Abstract

We prospectively studied 50 patients treated with interferon-alpha for chronic hepatitis and found no evidence that patients with a pre-existing mood or anxiety disorder were more likely than other patients to interrupt the interferon-alpha therapy.

Publication types

  • Letter

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Hepatitis B, Chronic / psychology
  • Hepatitis B, Chronic / therapy*
  • Hepatitis C, Chronic / psychology
  • Hepatitis C, Chronic / therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Male
  • Mood Disorders / complications*
  • Patient Compliance*
  • Survival Analysis

Substances

  • Interferon-alpha